These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 30097824)

  • 21. Trametinib (GSK1120212) in the treatment of melanoma.
    Salama AK; Kim KB
    Expert Opin Pharmacother; 2013 Apr; 14(5):619-27. PubMed ID: 23432625
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of trametinib on the neuropsychological profile of NF1 patients.
    Lalancette E; Cantin É; Routhier MÈ; Mailloux C; Bertrand MC; Kiaei DS; Larouche V; Tabori U; Hawkins C; Ellezam B; Décarie JC; Théoret Y; Métras MÉ; McKeown T; Ospina LH; Vairy S; Ramaswamy V; Coltin H; Sultan S; Legault G; Bouffet É; Lafay-Cousin L; Hukin J; Erker C; Caru M; Dehaes M; Jabado N; Perreault S; Lippé S
    J Neurooncol; 2024 May; 167(3):447-454. PubMed ID: 38443693
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeted therapy for infants with diencephalic syndrome: A case report and review of management strategies.
    Wagner LM; Myseros JS; Lukins DE; Willen CM; Packer RJ
    Pediatr Blood Cancer; 2018 May; 65(5):e26917. PubMed ID: 29369501
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Trametinib in metastatic melanoma.
    Chopra N; Nathan PD
    Expert Rev Anticancer Ther; 2015; 15(7):749-60. PubMed ID: 26107021
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Early experience with targeted therapy as a first-line adjuvant treatment for pediatric low-grade glioma.
    Leclair NK; Lambert W; Roche K; Gillan E; Gell JJ; Lau CC; Wrubel G; Knopf J; Amin S; Anderson M; Martin JE; Bookland MJ; Hersh DS
    Neurosurg Focus; 2022 Dec; 53(6):E15. PubMed ID: 36455272
    [TBL] [Abstract][Full Text] [Related]  

  • 26. KIAA1549: BRAF Gene Fusion and FGFR1 Hotspot Mutations Are Prognostic Factors in Pilocytic Astrocytomas.
    Becker AP; Scapulatempo-Neto C; Carloni AC; Paulino A; Sheren J; Aisner DL; Musselwhite E; Clara C; Machado HR; Oliveira RS; Neder L; Varella-Garcia M; Reis RM
    J Neuropathol Exp Neurol; 2015 Jul; 74(7):743-54. PubMed ID: 26083571
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pneumocephalus in a Pediatric Patient with Glioma Receiving Trametinib.
    Gorsi H; Marupudi NI; Sood S; Altinok D; Yankelevich M
    Pediatr Neurosurg; 2020; 55(1):51-53. PubMed ID: 31661699
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Surgical and molecular considerations in the treatment of pediatric thalamopeduncular tumors.
    Lee RP; Foster KA; Lillard JC; Klimo P; Ellison DW; Orr B; Boop FA
    J Neurosurg Pediatr; 2017 Sep; 20(3):247-255. PubMed ID: 28686121
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The distribution of BRAF gene fusions in solid tumors and response to targeted therapy.
    Ross JS; Wang K; Chmielecki J; Gay L; Johnson A; Chudnovsky J; Yelensky R; Lipson D; Ali SM; Elvin JA; Vergilio JA; Roels S; Miller VA; Nakamura BN; Gray A; Wong MK; Stephens PJ
    Int J Cancer; 2016 Feb; 138(4):881-90. PubMed ID: 26314551
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of Trametinib in Children and Young Adults With Progressive Low-grade Glioma and Glioneuronal Tumors.
    Hanzlik E; Archambault B; El-Dairi M; Schroeder K; Patel MP; Lipp ES; Peters KB; Ashley DM; Landi D
    J Pediatr Hematol Oncol; 2023 May; 45(4):e464-e470. PubMed ID: 36730221
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular characterization of disseminated pilocytic astrocytomas.
    Gessi M; Engels AC; Lambert S; Rothämel T; von Hornstein S; Collins VP; Denkhaus D; Gnekow A; Pietsch T
    Neuropathol Appl Neurobiol; 2016 Apr; 42(3):273-8. PubMed ID: 26084390
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeted MAPK Pathway Inhibitors in Patients With Disseminated Pilocytic Astrocytomas.
    Drobysheva A; Klesse LJ; Bowers DC; Rajaram V; Rakheja D; Timmons CF; Wang J; Koral K; Gargan L; Ramos E; Park JY
    J Natl Compr Canc Netw; 2017 Aug; 15(8):978-982. PubMed ID: 28784858
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phase II study of antineoplaston A10 and AS2-1 in children with recurrent and progressive multicentric glioma : a preliminary report.
    Burzynski SR; Weaver RA; Lewy RI; Janicki TJ; Jurida GF; Szymkowski BG; Khan MI; Bestak M
    Drugs R D; 2004; 5(6):315-26. PubMed ID: 15563234
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeted Therapy Win in BRAF-Mutant Gliomas.
    Cancer Discov; 2023 Nov; 13(11):2299-2300. PubMed ID: 37732735
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tamoxifen and carboplatin for children with low-grade gliomas: a pilot study at St. Jude Children's Research Hospital.
    Walter AW; Gajjar A; Reardon DA; Thompson SJ; Langston JW; Jones-Wallace D; Kun LE; Heideman RL
    J Pediatr Hematol Oncol; 2000; 22(3):247-51. PubMed ID: 10864056
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combined therapy with dabrafenib and trametinib in BRAF-mutated metastatic melanoma in a real-life setting: the INT Milan experience.
    Cavalieri S; Di Guardo L; Cimminiello C; Bono A; Tolomio E; Colombetti A; Valeri B; Di Tolla G; de Braud F; Del Vecchio M
    Tumori; 2016 Oct; 102(5):501-507. PubMed ID: 27470608
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety, pharmacokinetic, pharmacodynamic, and efficacy data for the oral MEK inhibitor trametinib: a phase 1 dose-escalation trial.
    Infante JR; Fecher LA; Falchook GS; Nallapareddy S; Gordon MS; Becerra C; DeMarini DJ; Cox DS; Xu Y; Morris SR; Peddareddigari VG; Le NT; Hart L; Bendell JC; Eckhardt G; Kurzrock R; Flaherty K; Burris HA; Messersmith WA
    Lancet Oncol; 2012 Aug; 13(8):773-81. PubMed ID: 22805291
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Trametinib Toxicities in Patients With Low-grade Gliomas and Diabetes Insipidus: Related Findings?
    Egan G; Hamilton J; McKeown T; Bouffet E; Tabori U; Dirks P; Bartels U
    J Pediatr Hematol Oncol; 2020 May; 42(4):e248-e250. PubMed ID: 30676433
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Temozolomide in pediatric low-grade glioma.
    Khaw SL; Coleman LT; Downie PA; Heath JA; Ashley DM
    Pediatr Blood Cancer; 2007 Nov; 49(6):808-11. PubMed ID: 17588234
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low grade chiasmatic-hypothalamic glioma-carboplatin and vincristin chemotherapy effectively defers radiotherapy within a comprehensive treatment strategy -- report from the multicenter treatment study for children and adolescents with a low grade glioma -- HIT-LGG 1996 -- of the Society of Pediatric Oncology and Hematology (GPOH).
    Gnekow AK; Kortmann RD; Pietsch T; Emser A
    Klin Padiatr; 2004; 216(6):331-42. PubMed ID: 15565548
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.